Skip to main navigation
  • Company
    • About Us
    • Leadership
    • Collaboration
    • Contact
  • Pipeline
    • Pipeline
    • Clinical Trials
  • Technology
    • Multiclonics® Platform
    • Publications
  • Investors & Media
    • Investors & Media Home
    • Financial Information
      • SEC Filings
      • Extraordinary General Meeting December 2019
      • Extraordinary General Meeting December 2019
      • Annual General Meeting 2019
      • Annual General Meeting 2018
      • Annual General Meeting 2017
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
      • Governance Contacts
      • Governance Documents
    • News Releases
    • Event Calendar
    • Analyst Coverage
    • Stock Information
    • FAQ's
    • Email Alerts
  • Careers
Menu
 

Annual General Meeting 2020

SubNav - Financial Information

  • SEC Filings
  • Annual General Meeting 2020
  • Extraordinary General Meeting December 31, 2019
  • Extraordinary General Meeting December 2019
  • Annual General Meeting 2019
  • Annual General Meeting 2018
  • Annual General Meeting 2017

Annual General Meeting 2020

Minutes 2020 AGM - Merus N.V.
June 30, 2020
Merus - Voting results AGM 2020
June 30, 2020
Merus N.V. – Annual Accounts and Report 2019
June 2, 2020
Proxy Card (AGM 2020)
June 2, 2020
Proposed Non-Executive Director Compensation Program (NED Program)
June 2, 2020
Convening Notice (AGM 2020)
June 2, 2020
Works Council Statement
June 2, 2020

Toolkit

  • RSS Feeds
  • E-mail Page
  • Print Page
  • E-mail Alerts
Explore
  • Company
  • Pipeline
  • Technology
  • Investors & Media
  • Careers
  • Contact
Contact Us

NL: +31 85 016 2500
Merus N.V., Yalelaan 62, 3584 CM Utrecht, The Netherlands
US: +1 617 401 4499
139 Main Street, Cambridge, MA 02142, USA
enquiries@merus.nl

© 2021 Merus - All rights reserved. Privacy Statement, Online Tracking Opt-Out Guide, Terms of Use & Community Guidelines.